FLT3 and acute myeloid leukemia: Clinically, AML patients with FLT3-ITD+ tend to have higher WBC counts and an increased percentage of leukemic blasts (Kottaridis et al., 2001; Yanada et al., 2005; Canaani et al., 2018).